Adriana Kahn, MD (@adrianakahnmd) 's Twitter Profile
Adriana Kahn, MD

@adrianakahnmd

Assistant Professor of Medicine (Oncology) @YaleCancer | Breast Cancer | Early Phase Clinical Trials

ID: 58145370

linkhttps://medicine.yale.edu/profile/adriana-kahn/ calendar_today19-07-2009 06:56:52

907 Tweet

1,1K Takipçi

1,1K Takip Edilen

Integrity CE SoMe CME (@somecme) 's Twitter Profile Photo

Don't miss the final #SABCSUpdates TONIGHT! 💬 Results from the phase 3 monarchE and NATALEE trials 👥 Aditya Bardia, MD, Adriana Kahn, MD, & Marija Sullivan 🕓 4:00 PM EST 📆 bit.ly/3t3Oifs #MedEd #FOAMed #BreastCancer

Don't miss the final #SABCSUpdates TONIGHT!

💬 Results from the phase 3 monarchE and NATALEE trials
👥 <a href="/dradityabardia/">Aditya Bardia, MD</a>, <a href="/AdrianaKahnMD/">Adriana Kahn, MD</a>, &amp; <a href="/marijasullivan/">Marija Sullivan</a>
🕓 4:00 PM EST
📆 bit.ly/3t3Oifs

#MedEd #FOAMed #BreastCancer
Integrity CE SoMe CME (@somecme) 's Twitter Profile Photo

1/💬 How does monarchE differ from other CDK4/6i trials? What is the significance/practical application of the subgroup analysis? 🎥 Aditya Bardia, MD will tell you all about it in the video below! #SABCSUpdates vimeo.com/895854180/9f91…

Integrity CE SoMe CME (@somecme) 's Twitter Profile Photo

3/ Is the benefit in monarchE or NATALEE sufficient to change your practice? #SABCSUpdates ET ± abema (monarchE) or ribo (NATALEE) for HR+/HER2– EBC: ↑ IDFS, consistent in subgroups, but diminished benefit w/ MYC amplification ↑ DRFS or DDFS OS trend ↑ but NS

3/ Is the benefit in monarchE or NATALEE sufficient to change your practice? #SABCSUpdates

ET ± abema (monarchE) or ribo (NATALEE) for HR+/HER2– EBC:
↑ IDFS, consistent in subgroups, but diminished benefit w/ MYC amplification
↑ DRFS or DDFS
OS trend ↑ but NS
Adriana Kahn, MD (@adrianakahnmd) 's Twitter Profile Photo

RIP Edith Mitchell, M.D. May your family have peace and comfort after such an unexpected loss… Thank you for your legacy and for all the lives you touched 😞♥️

#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

1/7 Multiple Antibody Drug Conjugates in #MBC= new options--can we use a different ADC after resistance to the first? 🚨 #TumorBoardTuesday case wrap up of Joannie M. Ivory, MD, MSPH, MHS & Yara Abdou's excellent discussion! Graphical summary 👇; read on to hear from the expert discussants!

1/7    Multiple Antibody Drug Conjugates in #MBC= new options--can we use a different ADC after resistance to the first?

🚨 #TumorBoardTuesday case wrap up of <a href="/drivorymd/">Joannie M. Ivory, MD, MSPH, MHS</a> &amp; <a href="/YAbdouMD/">Yara Abdou</a>'s excellent discussion! 

Graphical summary 👇; read on to hear from the expert discussants!
Adriana Kahn, MD (@adrianakahnmd) 's Twitter Profile Photo

When your 1-year old’s toddler school lunch is much better than yours…! I wish in public schools later this would also be a reality! For sure we would raise healthier food-conscious children. #food #children #publicschool

When your 1-year old’s toddler school lunch is much better than yours…!
I wish in public schools later this would also be a reality! For sure we would raise healthier food-conscious children. #food #children #publicschool
ASCO (@asco) 's Twitter Profile Photo

Experts review recent data & advances in drug development of anti-HER2 agents as they explore whether HER2-low is a unique #BreastCancer subtype: brnw.ch/21wI6qH #BCSM Maryam Lustberg MD, MPH, FASCO Adriana Kahn, MD David Rimm Yale Cancer Center @yalebreast #ASCODailyNews

Experts review recent data &amp; advances in drug development of anti-HER2 agents as they explore whether HER2-low is a unique #BreastCancer subtype: brnw.ch/21wI6qH #BCSM <a href="/maryam_lustberg/">Maryam Lustberg MD, MPH, FASCO</a> <a href="/AdrianaKahnMD/">Adriana Kahn, MD</a> <a href="/RimmPathology/">David Rimm</a> <a href="/YaleCancer/">Yale Cancer Center</a> @yalebreast #ASCODailyNews
Adriana Kahn, MD (@adrianakahnmd) 's Twitter Profile Photo

Enjoying friends and learning so much from the best breast oncologists in the world! Consortiums like this give us hope for a better future for patients with breast cancer! Translational Breast Cancer Research Consortium YaleBreastCancer

Enjoying friends and learning so much from the best breast oncologists in the world! Consortiums like this give us hope for a better future for patients with breast cancer! <a href="/TheTBCRC/">Translational Breast Cancer Research Consortium</a> <a href="/YaleBreast/">YaleBreastCancer</a>
Tendai Kwaramba, MD. MSc. (@kwarambat90) 's Twitter Profile Photo

What a fabulous oral presentation by our incredible chief fellow and superstar, Dr. Thejal Srikumar on our "Longitudinal curriculum to address wellness and professional development in a hematology/oncology fellowship program." Wow! #ASCO24 Yale Hematology Oncology Fellows Yale Cancer Center

What a fabulous oral presentation by our incredible chief fellow and superstar, Dr. Thejal Srikumar on our "Longitudinal curriculum to address wellness and professional development in a hematology/oncology fellowship program." Wow! #ASCO24 <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> <a href="/YaleCancer/">Yale Cancer Center</a>
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Congratulations to all the Yale Hematology/Oncology fellows on successfully completing another remarkable year! We look forward to the exciting adventures that the next year will bring... starting with meeting our new fellows tomorrow!

Congratulations to all the Yale Hematology/Oncology fellows on successfully completing another remarkable year! We look forward to the exciting adventures that the next year will bring... starting with meeting our new fellows tomorrow!
Sandy Cassanelli (@sandycassanelli) 's Twitter Profile Photo

Caring for Metastatic Breast Cancer: A Conference for Patients & Caregivers,” a special in-person program on Saturday, October 5, from 9:00am to 2:00pm The full agenda and registration using this link: bit.ly/Caring-for-MBC Yale Cancer Center YaleBreastCancer Smilow Cancer Hospital

Caring for Metastatic Breast Cancer: A Conference for Patients &amp; Caregivers,” a special in-person program on Saturday, October 5, from 9:00am to 2:00pm 
The full agenda and registration using this link: 
bit.ly/Caring-for-MBC
<a href="/YaleCancer/">Yale Cancer Center</a>  <a href="/YaleBreast/">YaleBreastCancer</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a>